Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NITRATE-CIN: Inorganic Nitrate for CIN Prevention in ACS
NCT03627130Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Nov 2018
- Primary completion
- May 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in contrast-induced nephropathy (CIN) comparing Potassium Nitrate with Placebo (2 arms). Primary endpoint: Contrast Induced Nephropathy. Started Nov 2018; status: completed.
02
Drugs
potassium nitrate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT03627130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03627130.